Cargando…

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]

Detalles Bibliográficos
Autores principales: Yang, Xin, Zhu, Ying, Zhao, Xia, Li, Jian-Hua, Xu, Da, Jia, Hu-Liang, Zhang, Jubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884955/
https://www.ncbi.nlm.nih.gov/pubmed/33603477
http://dx.doi.org/10.2147/CMAR.S304083
_version_ 1783651523062923264
author Yang, Xin
Zhu, Ying
Zhao, Xia
Li, Jian-Hua
Xu, Da
Jia, Hu-Liang
Zhang, Jubo
author_facet Yang, Xin
Zhu, Ying
Zhao, Xia
Li, Jian-Hua
Xu, Da
Jia, Hu-Liang
Zhang, Jubo
author_sort Yang, Xin
collection PubMed
description
format Online
Article
Text
id pubmed-7884955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78849552021-02-17 Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] Yang, Xin Zhu, Ying Zhao, Xia Li, Jian-Hua Xu, Da Jia, Hu-Liang Zhang, Jubo Cancer Manag Res Response to Letter Dove 2021-02-11 /pmc/articles/PMC7884955/ /pubmed/33603477 http://dx.doi.org/10.2147/CMAR.S304083 Text en © 2021 Yang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Yang, Xin
Zhu, Ying
Zhao, Xia
Li, Jian-Hua
Xu, Da
Jia, Hu-Liang
Zhang, Jubo
Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title_full Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title_fullStr Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title_full_unstemmed Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title_short Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
title_sort hepatocellular carcinoma with portal vein tumor thrombus versus hepatocellular carcinoma with biliary tumor thrombus: better or worse prognoses? [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884955/
https://www.ncbi.nlm.nih.gov/pubmed/33603477
http://dx.doi.org/10.2147/CMAR.S304083
work_keys_str_mv AT yangxin hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT zhuying hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT zhaoxia hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT lijianhua hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT xuda hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT jiahuliang hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter
AT zhangjubo hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter